© Reuters. FILE PHOTO: Vial and medical syringe appear in front of the Moderna logo in this image
(Reuters) – Moderna (NASDAQ 🙂 Inc on Monday raised the lower end of its 2021 forecast for COVID-19 vaccine production by 100 million doses.
The company increased it from 500 million cans previously to 600 million cans.
Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. As a result, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading loss you may incur as a result of using this information.
Fusion Media or any person involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts and buy / sell signals. Please be fully informed about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.